Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2010

View Archived Issues

Memantine reduces "off" time in Parkinson's disease

PYM-50028 can be delivered to patients with PD at preclinically efficacious doses

Proximagen Neuroscience claims new SSAO inhibitors

New JAK3 kinase inhibitors identified by Roche

Novartis claims new chemokine CXCR2 receptor antagonists

Astellas submits MAA for mirabegron in Japan

Taxus Element paclitaxel-eluting stent system launched in Europe

Roche amends trial protocols for taspoglutide phase III program

Phase I/II trial of new proapoptotic agent APR-246 advances

PX-478 shows antitumor activity in phase I trial in advanced solid tumors

177Lu-J591 shows safety and preliminary efficacy in metastatic CRPC

ALD-518 improves rheumatoid arthritis symptoms in phase II trial

FDA recommends approval of emergency contraceptive ulipristal

Bionomics completes phase I trial of BNC-210 for anxiety

Mitsubishi Tanabe's Remicade approved for ulcerative colitis in Japan

FDA committee recommends additional clinical testing to support flibanserin NDA

Valeant and Biovail agree to merge

Hematide shows promise to treat anemia in phase III trials in CRF

BL-1020 improves schizophrenia symptoms in phase IIb trial

Amplyx Pharmaceuticals presents novel carbapenems

Zydus receives permission for phase I trial of ZYOG-1 in India

Lodotra now available in 13 European countries for RA

Sosei to acquire Activus Pharma

FDA advises on phase III palifosfamide trial in metastatic soft tissue sarcoma

Exelixis regains rights to XL-184

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...